What Navigene does
Founded in 2012, Navigene operates in Health Tech offering genetic screening, diagnostic, and research solutions. The company focuses on non-invasive preventive testing, including newborn screening, metabolic fingerprinting, and prenatal screening, while also providing diagnostic testing in cytogenetics and molecular genetics. Navigenes flagship product, Navigene Baby Screen, allows for the detection of 110 genetic and metabolic disorders from a urine sample just three days after birth. With over 30 hospital partnerships and a presence in all major metropolitan areas, Navigene aims to enhance its growth trajectory and expand its reach in the genetic diagnostics market. The company is committed to innovating in testing techniques and diagnostic machinery.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Navigene yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.